Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating encouraging results in the control of type 2 diabetes. This synthetic peptide resembles the actions of naturally produced GLP-1, a https://olivebookmarks.com/story20914351/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes